SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue128,367146,444162,556
Cost of Revenue47,21835,84327,689
Gross Profit81,149110,601134,867
Operating Expenses
Research Development65,89559,12351,073
Selling General and Administrative84,26788,41888,064
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-96,660-62,886-42,589
Income from Continuing Operations
Total Other Income/Expenses Net-4,568238-573
Earnings Before Interest and Taxes-101,228-62,648-43,162
Interest Expense6,7989,4359,074
Income Before Tax-108,026-72,083-52,236
Income Tax Expense-16,778-2,313406
Minority Interest---
Net Income From Continuing Ops-91,248-69,770-52,642
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-91,248-69,770-52,642
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-91,248-69,770-52,642